Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2025-12-25 @ 8:43 PM
Study NCT ID:
NCT01857869
Status:
COMPLETED
Last Update Posted:
2019-06-26
First Post:
2013-05-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2014-03-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12-16
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-16
First Submit QC Date:
None
Study First Post Date:
2013-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-25
Results First Submit QC Date:
None
Results First Post Date:
2018-12-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-06-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-06-11
Last Update Post Date:
2019-06-26
Last Update Post Date Type:
ACTUAL